x

Cerca una sperimentazione clinica

* (*) campo obbligatorio

54 Risultato/i

Ordinato per

Sperimentazione in fase di reclutamento = Sperimentazione in fase di reclutamento
; Sperimentazione in corso = Sperimentazione in corso
; Finanziato da un ente associato a IRDiRC =

Sperimentazioni cliniche nazionali

AUSTRIA

WIEN
WIEN

Sperimentazione in fase di reclutamento
Sperimentazione in corso
High Risk Neuroblastoma Study 1 of SIOP-Europe (SIOPEN) (Phase III) - AT
St. Anna Kinderspital
Zentrum für Kinder- und Jugendheilkunde

AUSTRIA

WIEN
WIEN

Sperimentazione in fase di reclutamento
Sperimentazione in corso
LINES: European Low and Intermediate Risk Neuroblastoma Protocol (Phase III) - AT
St. Anna Kinderspital
Zentrum für Kinder- und Jugendheilkunde

FRANCIA

ILE-DE-FRANCE
VILLEJUIF

Phase 2 single-arm study of gemcitabine in combination with oxaliplatin in refractory and relapsed pediatric solid tumors - Terminated -
CLCC Institut Gustave Roussy
Département de cancérologie de l'enfant et de l'adolescent

FRANCIA

ILE-DE-FRANCE
VILLEJUIF

FRANCIA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

GERMANIA

Mecklenburg-Vorpommern
GREIFSWALD

GERMANIA

Nordrhein-Westfalen
KÖLN

GERMANIA

Nordrhein-Westfalen
MÜNSTER

Doxo: Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia - DE - Completed
Universitätsklinikum Münster
Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie

IRLANDA

County Dublin
DUBLIN

European Infant Neuroblastoma Study Final Protocol (Phase III) - IE
Our Lady's Children's Hospital
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

IRLANDA

County Dublin
DUBLIN

Management of Children Aged Less Than 3 Years With Brain Tumors (Phase II) - IE
Our Lady's Children's Hospital
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

IRLANDA

County Dublin
DUBLIN

Phase II Study of Temozolomide (Temodal) in Children Over 1 Year of Age With Relapsed or Refractory High Risk Neuroblastoma - IE
Our Lady's Children's Hospital
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

IRLANDA

County Dublin
DUBLIN

Phase II Trial of Surgery as the Only Treatment for INSS Stage 2A & 2B Neuroblastoma - IE
Our Lady's Children's Hospital
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

IRLANDA

County Dublin
DUBLIN

PAESI BASSI

Noord-Holland
AMSTERDAM

Sperimentazione in corso
Surgery in Treating Patients With Neuroblastoma
AMC - Academisch Medisch Centrum
Polikliniek Kinderoncologie

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

Sperimentazione in fase di reclutamento
Sperimentazione in corso
NB 2002 06: High Risk Neuroblastoma Study 1 Of Siop-Europe (Phase III) - UK
Great Ormond Street Hospital for Children, NHS Foundation Trust
The Somers Clinical Research Facility Level 1

REGNO UNITO; GRAN BRETAGNA

Greater Manchester
MANCHESTER

REGNO UNITO; GRAN BRETAGNA

Surrey
SUTTON

REGNO UNITO; GRAN BRETAGNA

Tyne & Wear
NEWCASTLE UPON TYNE

Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia - UK
Northern Institute for Cancer Research, Medical School, Newcastle University
Northern Institute for Cancer Research

SPAGNA

Comunidad Valenciana
VALENCIA

Sperimentazione in fase di reclutamento
High Risk Neuroblastoma Study 1 Of Siop-Europe (Phase III) - ES
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de Investigación Clínica y Traslacional en Cáncer

SPAGNA

Comunidad Valenciana
VALENCIA

SPAGNA

Comunidad Valenciana
VALENCIA

Sperimentazione in fase di reclutamento
Sperimentazione in corso
European Low and Intermediate Risk Neuroblastoma Protocol (Phase III) - ES
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de Investigación Clínica y Traslacional en Cáncer

SPAGNA

Comunidad Valenciana
VALENCIA

Sperimentazione in fase di reclutamento
Sperimentazione in corso
BEACON-Neuroblastoma Trial: A randomised phase IIb trial of bevacizumab added to temozolomide ± irinotecan for children with refractory/relapsed neuroblastoma - ES
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de Investigación Clínica y Traslacional en Cáncer

REGNO UNITO; GRAN BRETAGNA

Greater Manchester
NOT YET IDENTIFIED - UK

REGNO UNITO; GRAN BRETAGNA

Greater Manchester
NOT YET IDENTIFIED - UK